What is the appropriate dosing and administration of naloxone (Narcan) for opioid overdose?

Naloxone Dosing and Administration for Opioid Overdose

For opioid overdose with respiratory depression or arrest, administer naloxone immediately while prioritizing airway support and ventilation—start with intranasal 2 mg or intramuscular 0.4 mg, repeat every 2-3 minutes as needed, and always activate emergency services because naloxone's duration is shorter than most opioids. 1, 2

Critical First Steps

The absolute priority is airway management and rescue breathing—naloxone takes several minutes to work, particularly via intranasal or intramuscular routes, and the patient may die from hypoxia before the drug takes effect 1. Open the airway, provide rescue breaths with a bag-mask or barrier device, and call 911 immediately. Do not delay CPR or ventilation to search for or administer naloxone.

Dosing by Route

Intranasal Administration

• Initial dose: 2 mg in one nostril (this is the FDA-approved dose for the commercial nasal spray) 2
• Position patient supine with head tilted back, supporting the neck
• If no response after 2-3 minutes, give another 2 mg dose in the alternate nostril using a new device 2
• Each nasal spray device is single-use only

Intramuscular/Intravenous Administration

• Start with 0.4 mg IV or IM to minimize precipitating severe withdrawal in opioid-dependent patients 3
• If inadequate response, escalate to 2 mg IV or IM 3
• IV onset is 1-2 minutes; IM takes slightly longer 4

Important nuance: While the 2015 AHA guidelines suggested starting with 0.04-0.4 mg IV/IM 3, the 2025 AHA guidelines emphasize that intranasal 2 mg is appropriate for lay rescuers and first responders 1. Research shows 0.4 mg intranasal is equally effective as 2 mg with fewer adverse effects 5, but commercial devices deliver 2 mg, which remains safe and effective.

Repeat Dosing

Redose every 2-3 minutes if:

• Patient remains unresponsive
• Respiratory depression persists
• Patient initially responds but relapses into respiratory depression 1, 2

There is no maximum dose—continue administering naloxone until the patient breathes adequately or emergency services arrive. Most patients respond to 1-2 doses, but some require more 1.

Special Circumstances

Buprenorphine or Partial Agonist Overdose

Higher or repeated doses are required because buprenorphine binds tightly to opioid receptors and dissociates slowly 2. Expect gradual onset of reversal and be prepared to administer multiple doses 2.

Fentanyl and Synthetic Opioids

Contrary to popular belief, fentanyl overdoses do not require higher naloxone doses 6. Standard dosing (0.4-2 mg) is equally effective for fentanyl as for heroin 6, 7. The key difference is that fentanyl may require more frequent redosing due to its pharmacokinetics, not higher individual doses 8.

Cardiac Arrest

If the patient is in cardiac arrest (no pulse), naloxone is unlikely to restore circulation on its own 1, 9. Provide high-quality CPR immediately and continuously. Administer naloxone during CPR if available, but never delay chest compressions to give naloxone 1, 9.

Critical Warnings

Risk of Recurrent Depression

Naloxone's duration of action (30-90 minutes) is shorter than most opioids 10, 4, 2. Patients who initially respond can relapse into respiratory depression, especially with long-acting opioids like methadone or sustained-release formulations 9, 10, 2.

After successful reversal:

• Keep patient under continuous observation for at least 2 hours 9, 4
• Transport to hospital even if patient refuses—they lack capacity to refuse when at risk of recurrent overdose 9
• Consider naloxone infusion for long-acting opioid overdoses 9

Precipitated Withdrawal

Naloxone can trigger acute withdrawal in opioid-dependent patients, causing agitation, hypertension, tachycardia, vomiting, and severe discomfort 3, 2. While rarely life-threatening in adults, neonatal withdrawal can be life-threatening with seizures and hyperactive reflexes 2.

To minimize withdrawal:

• Use the lowest effective dose (start with 0.4 mg IV/IM rather than 2 mg when IV access available) 3
• Titrate to adequate respirations, not full consciousness 3
• Goal is restoring breathing, not making patient fully alert

However, in lay rescuer situations with intranasal naloxone, saving the patient's life takes precedence over avoiding withdrawal symptoms 1, 2.

Post-Resuscitation Management

After return of spontaneous breathing:

• Observe in healthcare setting until risk of recurrent toxicity is low 9
• Monitor vital signs and level of consciousness continuously 9
• If recurrent toxicity develops, give repeated small doses or start naloxone infusion 9
• Longer observation required for methadone, sustained-release opioids, or unknown substances 9, 10

Common Pitfalls

1. Delaying airway management to give naloxone—ventilation comes first 1
2. Giving naloxone to cardiac arrest patients instead of CPR—naloxone doesn't reverse cardiac arrest 1, 9
3. Allowing patients to refuse transport after reversal—they will likely re-overdose 9, 2
4. Assuming one dose is sufficient—have multiple doses ready 1, 2
5. Expecting immediate response—intranasal/IM naloxone takes several minutes 1